MaculaPM® Ingredients
Proactive Eye Health for Your Macula & Retina
L-DOPA
L-DOPA is the key ingredient that makes MaculaPM® different from standard eye health supplements. We included it based on scientific research supporting its role in healthy retinal function and visual signaling.
Vitamin C
Vitamin C helps support the eye’s natural antioxidant defenses. We included it to help protect cells from oxidative stress and support overall eye wellness.
Vitamin E
Vitamin E is a key antioxidant that helps support cell health by protecting against free radical damage. We included it as part of a comprehensive nutritional approach to long-term eye health.
Melatonin
Melatonin was included because it is a natural nighttime compound that supports the body’s normal overnight restorative processes. It also provides antioxidant support, making it a strong fit for MaculaPM®’s nighttime formula.
Lutein
Lutein is one of the best-known nutrients for macular health. We included it to support macular pigment, visual performance, and the eye’s natural ability to filter blue light.
Zeaxanthin
Zeaxanthin works together with lutein and is also concentrated in the macula. We included it to support central visual function, macular health, and antioxidant protection.
Meet the Medical Team Behind MaculaPM®
John A. Martens
With degrees in Chemical Engineering and Chemistry, John Martens has decades of experience as a scientist, engineer and product innovator. He served as a corporate scientist for 35 years at 3M Corporation, and he has been involved in the development of products and technologies for numerous nutraceutical, pharmaceutical and biomedical products related to the treatment of eye diseases.
Learn More
Dr. Murray H. Brilliant
Dr. Brilliant has a degree in Biology and received his doctorate in Molecular Cell & Developmental Biology. He is currently a professor of Ophthalmology at the University of Arizona where he has a research focus in areas related to macular degeneration. Dr. Brilliant headed the research project that identified the profound protective benefits of L-DOPA on age-related macular degeneration.
Learn More
Robert W. Snyder
MD, PhD, PC
Dr. Snyder has extensive clinical experience as well as a PhD in microbiology/cell biology. He has received peer reviewed funding for both clinical research and trials, as well as basic research. He served as the Chairman of Ophthalmology at The University of Arizona where he received numerous grants, clinical trials and NIH funding for research related to macular degeneration.
Learn More
Dr. Brian McKay
Dr. McKay is a leading researcher with extensive experience in ophthamology, macular degeneration and other vision-related research. Dr. McKay earned his Ph.D. at the Medical College of Wisconsin. He also received postdoctoral training at The Scripps Institute, and he currently serves as a course director in the vision science colloquium at the University of Arizona.
Learn More
About Tech Launch Arizona
The University of Arizona is a place of learning, invention and discovery. Tech Launch Arizona collaborates with creators and the local community to help bring those discoveries to the world through commercial pathways. The primary focus is ensuring that innovations originating with U of A faculty, researchers, staff and students find meaningful applications that benefit the public.
